1- In adults :

• Symptomatic treatment of gastroesophageal reflux, with or without esophagitis, in case of resistance or inadequate response to first-line treatments.
• Maintenance treatment of grade III and IV gastroesophageal reflux-associated esophagitis.

2- In children from one year of age :

• Gastroesophageal reflux-associated esophagitis (esophagitis should be objectively confirmed by the presence of erosions or ulcers during endoscopy).

Hypertension accompanied by visceral damage that threatens short-term vital prognosis (hypertensive emergency), particularly in cases of :

• Hypertensive encephalopathy.
• Left ventricular decompensation with pulmonary edema.
• Cardiological emergencies: acute pulmonary edema, asystole.
• Severe sodium retention of cardiac, renal, or cirrhotic origin.
• Radiology of the lower urinary tract and « wash out » test with furosemide.
• Can be used in pediatric reanimation.

ENOXA is indicated in adults for :

ENOXA is indicated in adults for :

ENOXA is indicated in adults for :

ENOXA is indicated in adults for :

1- In immunocompromised patients :

• Varicella Zoster virus (VZV) infections.
• Herpes Simplex virus (HSV) infections.

2- In immunocompetent patients :

1- In immunocompromised patients :

• Varicella Zoster virus (VZV) infections.
• Herpes Simplex virus (HSV) infections.

2- In immunocompetent patients :

Prevention of herpes simplex virus infections in immunocompromised subjects.

In immunocompetent subjects:

Skin or mucosal infections :

The indications are :